Rational Combinations 360° Speakers
Laszlo Radvanyi, PhD
SVP & Global Head of Immuno-Oncology Translational Innovation Platform
Laszlo Radvanyi earned his PhD degree in Clinical Biochemistry in 1996 at the University of Toronto, Toronto, Canada. Dr Radvanyi joined EMD Serono (Merck KGaA, Darmstadt Germany) in November 2015 and is currently a Senior Vice President (SVP), Global Senior Scientific Advisor in Immunology and Immuno-Oncology at EMD Serono where he plays a central scientific advisory role for all immuno-oncology and immunology programs and develops major academic center alliances. Prior to this, he was the Global Head of the Immuno-Oncology Translational Innovation Platform where he oversaw the day-to-day research operations in immuno-oncology at the company for 1.5 years. Before joining EMD Serono, Dr Radvanyi was a Professor in the Department of Melanoma Medical Oncology at the University of Texas, MD Anderson Cancer Center in Houston for about 10 years. While at MD Anderson, he established a GMP-grade T-cell therapy manufacturing program for metastatic melanoma using expanded tumor-infiltrating lymphocytes (TIL) and performed pre-clinical research on TIL biology and effector function focusing on TNF-R family costimulation and CD8+ T-cell differentiation. Dr Radvanyi was also the founding CSO for Lion Biotechnologies for 1.5 years and built the biotech’s R&D infrastructure in Tampa, FL and lead development activities leading to two IND submissions. Dr Radvanyi has authored over 100 papers, has served on the advisory board of a number of pharma and biotech companies, reviewed for numerous journals in the tumor immunology space, and has sat on a number of national and international grant review panels. He is on the Keystone Conferences Scientific Advisory Board, is on editorial board of the Journal of Immunotherapy for Cancer (JITC), and sits on the Industry Advisory Council of SITC.